BioPharma Pharma Research
With an impact factor of 47.99, Nature Methods is the world's leading international publication for biochemical research methodology. Upon public...
May 05, 2023 | News
Nous-209 has been developed using the Nouscom's viral vector platform, which includes adenoviral and Modified Vaccinia Ankara (MVA) vectors, with MVA vecto...
May 04, 2023 | News
Digital health has revolutionized the way healthcare is delivered and managed in recent years. Oncology is one field that has benefited significantly from ...
May 03, 2023 | Opinion
MRA-funded research spans the entire spectrum of the disease including melanoma prevention, diagnosis, treatment, and metastatic disease. Melanoma is the d...
May 02, 2023 | News
-Lead Program, Avacincaptad Pegol for the Potential Treatment of Geographic Atrophy with PDUFA Goal Date of August 19, 2023- -Acquisition advances A...
May 01, 2023 | News
The results were featured in a late-breaking oral presentation delivered on Sunday, 30 April 2023 (CST) by Associate Professor Brian Shuch, ...
May 01, 2023 | News
Over 250 events expected to reach more than 45,000 future scientists on two continents Hands-on experiments to focus on impact of contamination on the p...
April 30, 2023 | News
Toshiba Energy Systems & Solutions Corporation (hereinafter "Toshiba ESS") is pleased to announce today the commencement of treatment using a heavy ion...
April 30, 2023 | News
The MALETH Project, which was led by Professor Joseph Borg from the University of Malta brought internationally excelling scientists to...
April 30, 2023 | Company results
Although there are currently 30 million chronic headache patients in Japan, the diagnosis and treatment rate of migraine among non-headache specialist...
April 28, 2023 | News
Exclusive rights for the development and commercialization of DWP213388 in the global market to Vitalli Bio, a portfolio company of Aditum Bio, the biotech...
April 28, 2023 | News
Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Theragen Bio in South Korea to ...
April 26, 2023 | News
Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...
April 26, 2023 | News
The Phase 3 trial is a randomized, controlled, open-label, multi-center study to evaluate the efficacy and safety of lemzoparlimab in combination with AZA ...
April 25, 2023 | News
Most Read
Bio Jobs
News
Editor Picks